Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4⁺ T-cell hypersecretion of IL-17A and IL-8 in humans

References

• Cronstein BN, Sitkovsky M. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol. 2017;13(1):41–51.
   PubMed Web of Science ®Google Scholar
• Ciruela F, Albergaria C, Soriano A, et al. Adenosine receptors interacting proteins (ARIPs): behind the biology of adenosine signaling. Biochim Biophys Acta. 2010;1798(1):9–20.
   PubMed Web of Science ®Google Scholar
• Fredholm BB, Arslan G, Halldner L, et al. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol. 2000;362(4–5):364–374.
   PubMed Web of Science ®Google Scholar
• Livingston M, Heaney LG, Ennis M. Adenosine, inflammation and asthma—a review. Inflamm Res. 2004;53(5):171–178.
   PubMed Web of Science ®Google Scholar
• Mori A, Shindou T. Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists. Neurology. 2003;61(11 Suppl 6):S44–S8.
   PubMedGoogle Scholar
• Takahashi M, Fujita M, Asai N, et al. Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan. Expert Opin Pharmacother. 2018;19(15):1635–1642.
   PubMed Web of Science ®Google Scholar
• Wilson JM, Kurtz CC, Black SG, et al. The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6. J Immunol. 2011;186(12):6746–6752.
   PubMed Web of Science ®Google Scholar
• Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol. 2007;51(12):1139–1147.
   PubMed Web of Science ®Google Scholar
• Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol. 2008;9(6):641–649.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol. 2007;19(6):409–417.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71(1):1–8.
   PubMed Web of Science ®Google Scholar
• Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity. 2004;21(4):467–476.
   PubMed Web of Science ®Google Scholar
• Qing W, Jing L, Min J, et al. Relationship between Th17-mediated immunity and airway inflammation in childhood neutrophilic asthma. Allergy Asthma Clin Immunol. 2021;17:4.
   PubMed Web of Science ®Google Scholar
• Sofia de Oliveira CC, Sergio C, Stephen AR, et al. Cxcl8 (IL-8mediates neutrophil recruitment and behavior in the zebrafish inflammatory response. J Immunol. 2013;190(8):4349–4359.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28(4):454–467.
   PubMed Web of Science ®Google Scholar
• Tesmer LA, Lundy SK, Sarkar S, et al. Th17 cells in human disease. Immunol Rev. 2008;223:87–113.
   PubMed Web of Science ®Google Scholar
• Ogura H, Murakami M, Okuyama Y, et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity. 2008;29(4):628–636.
   PubMed Web of Science ®Google Scholar
• Leng RX, Chen GM, Pan HF, et al. The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet’s disease. Clin Rheumatol. 2010;29(10):1209.
   PubMed Web of Science ®Google Scholar
• Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behçet’s disease. Curr Opin Pharmacol. 2004;4(2):183–188.
   PubMed Web of Science ®Google Scholar
• Hirota K, Hashimoto M, Yoshitomi H, et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med. 2007;204(1):41–47.
   PubMed Web of Science ®Google Scholar
• Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol. 2006;177(1):566–573.
   PubMed Web of Science ®Google Scholar
• Matusevicius D, Kivisäkk P, He B, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999;5(2):101–104.
   PubMed Web of Science ®Google Scholar
• Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol. 2011;74(1):1–13.
   PubMed Web of Science ®Google Scholar
• Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8(5):500–508.
   PubMed Web of Science ®Google Scholar
• Vaknin-Dembinsky A, Balashov K, Weiner HL. IL-23 is increased in dendritic cells in multiple sclerosis and downregulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol. 2006;176(12):7768–7774.
   PubMed Web of Science ®Google Scholar
• Pierson ER, Wagner CA, Goverman JM. The contribution of neutrophils to CNS autoimmunity. Clin Immunol. 2018;189:23–28.
   PubMed Web of Science ®Google Scholar
• McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol. 2008;181(6):4089–4097.
   PubMed Web of Science ®Google Scholar
• Lindén A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001;126(3):179–184.
   PubMed Web of Science ®Google Scholar
• Rizzo HL, Kagami S, Phillips KG, et al. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. JI. 2011;186(3):1495–1502.
   Google Scholar
• Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL-17-producing gamma delta T cells in skin inflammation. Immunity. 2011;35(4):596–610.
   PubMed Web of Science ®Google Scholar
• Nakae SY, Komiyama A, Nambu K, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17(3):375–387.
   PubMed Web of Science ®Google Scholar
• Nakano K, Yamaoka K, Hanami K, et al. Dopamine induces IL-6_dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol. 2011;186(6):3745–3752.
   PubMed Web of Science ®Google Scholar
• Nakagome K, Imamura M, Okada H, et al. Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and OVA-Ag-induced neutrophilic airway inflammation. J Immunol. 2011;186(10):5975–5982.
   PubMed Web of Science ®Google Scholar
• Arreola R, Alvarez-Herrera S, Pérez-Sánchez G, et al. Immunomodulatory effects mediated by dopamine. J Immunol Res. 2016;2016:3160486.
   PubMed Web of Science ®Google Scholar
• Tokano M, Matsushita S, Takagi R, et al. Extracellular adenosine induces hypersecretion of IL-17A by T-helper 17 cells through the adenosine A2a receptor to promote neutrophilic inflammation. bioRxiv. 2021. 441713. https://doi.org/10.1101/2021.04.29.441713
   Google Scholar
• Tokano M, Kawano M, Takagi R, et al. Istradefylline, an adenosine A2a receptor antagonist, ameliorates neutrophilic airway inflammation and psoriasis in mice. Clinical & Exp Neuroim. 2021;12(4):268–275.
   Google Scholar
• Drug information of istradefylline. Available from: https://medical.kyowakirin.co.jp/druginfo/detail/nouriast-tablets-20mg/index.html
   Google Scholar
• Matsuyama T, Kawano M, Takagi R, et al. IL-8 produced by T cells is under the control of dopamine signaling. Clin Exp Neuroimmunol. 2018;9(4):251–257.
   Google Scholar
• Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 2001;79(3):463–484.
   PubMed Web of Science ®Google Scholar
• Monks CR, Kupfer H, Tamir I, et al. Selective modulation of protein kinase C-theta during T-cell activation. Nature. 1997;385(6611):83–86. 1997
   PubMed Web of Science ®Google Scholar
• Matsushita S, Higashi T. Human Th17 cell clones and natural immune responses. Allergol Int. 2008;57(2):135–140.
   PubMedGoogle Scholar
• Parackova Z, Bloomfield M, Klocperk A, et al. Neutrophils mediate Th17 promotion in COVID-19 patients. J Leukoc Biol. 2021;109(1):73–76.
   PubMed Web of Science ®Google Scholar
• Betsy J, Barnes Jose MA, Amelia BS, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652.
   PubMed Web of Science ®Google Scholar
• Xu Z, Lei S, Yijin W, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422.
   PubMed Web of Science ®Google Scholar
• Henderson LA, Scott WC, Grant SS, et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020;72(7):1059–1063.
   PubMed Web of Science ®Google Scholar
• Middleton EA, He X-Y, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–1179.
   PubMed Web of Science ®Google Scholar
• Parackova Z, Zentsova I, Bloomfield M, et al. Disharmonic inflammatory signatures in COVID-19: augmented neutrophils’ but impaired monocytes’ and dendritic cells’ responsiveness. Cells. 2020;9(10):2206.
   PubMed Web of Science ®Google Scholar
• Tomar B, Anders H, Desai J, et al. Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19. Cells. 2020;9(6):1383.
   PubMed Web of Science ®Google Scholar
• Sahebnasagh A, Saghafi F, Safdari M, et al. Neutrophil elastase inhibitor (sivelestatmay be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. J Clin Pharm Ther. 2020;45(6):1515–1519.
   PubMed Web of Science ®Google Scholar
• Tokano M, Takagi R, Kawano M, et al. Signaling via dopamine and adenosine receptors modulate viral peptide-specific and T-cell IL-8 response in COVID-19. Immunol Med. 2022. DOI: 10.1080/25785826.2022.2079369
   Google Scholar
• Borroto-Escuela DO, Luca F, Manuel N, et al. Multiple Adenosine-Dopamine (A2A-D2 likeheteroreceptor complexes in the brain and their role in schizophrenia. Cells. 2020;9(5):1077.
   PubMed Web of Science ®Google Scholar
• Yabuuchi K, Kuroiwa M, Shuto T, et al. Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum. Neuroscience. 2006;141(1):19–25.
   PubMed Web of Science ®Google Scholar
• Anna RH, Heather RC, Nydiaris H, et al. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol. 2014;192:1745–1752.
   PubMed Web of Science ®Google Scholar
• Carl S, Thomas F, Paul L, et al. The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks. Schizophr. Bull. 2014;40:1552–1559.
   PubMed Web of Science ®Google Scholar
• Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97(14):8104–8109.
   PubMed Web of Science ®Google Scholar
• Srinivasa RB, Sylviane M. Parkinson's disease is an autoimmune disease: a reappraisal. Autoimmun Rev. 2020;19:102684.
   PubMed Web of Science ®Google Scholar